Dopamine Transporter Imaging in Neurological Practice Web cast
September 22, 2006 – London, United Kingdom
Faculty
Course Directors
Andrew Lees, MD, FRCP
Rita Lila Weston Institute of Neurological Sciences
London, UK
Durval Costa, MD, MSc, PhD, FRCR
University of Coimbra and HPP Medicina Molecular, SA
Porto, Portugal
Faculty
Angelo Antonini, MD, PhD
Parkinson Center - ICP
Milan, Italy
Svetislav Gacinovic, MD, MSc
University College London Hospital
London, United Kingdom
Donald Grosset, BSc, MBChB, MD, FRCP
Southern General Hospital
Glasgow, United Kingdom
Philippe Remy, MD, PhD
CHU Henri Mondor
Orsay, France
Christoph Scherfler
University Hospital Innsbruck
Innsbruck, Austria
Course Advisory Panel
Andrew Lees, MD, FRCP
Reta Lila Weston Institute of Neurological Studies
London, UK
Werner Poewe, MD
University Hospital Innsbruck
Innsbruck, Austria
Eduardo Tolosa, MD
Hospital Clinic Universitari
Barcelona, Spain
Wolfgang Oertel, MD
Philipps University of Marburg
Marburg, Germany
Relationship Disclosure Policy
It is the policy of The Movement Disorder Society (MDS) to ensure balance, independence, objectivity, and scientific rigor in all MDS sponsored educational activities. All planning committee and faculty members participating in any MDS sponsored activity are required to disclose to MDS and the activity audience all relevant financial relationships with any commercial interest.
The intent of this policy is not to prevent a speaker with a potential conflict of interest from making a presentation. It is merely intended that any potential conflict should be identified and resolved prior to the activity, so that there is no commercial bias present in the presentation.
Planning Committee and Faculty Relationship Disclosure
The course planning committee and speakers have reported financial interests or relationships with the following manufacturer(s) of commercial products, services, technologies or programs:
Angelo Antonini, MD, PhD
Prof. Antonini is a consultant for Boehringer Ingelheim, Novartis, GE Healthcare, and Pfizer, and has also received honoraria from Boehringer Ingelheim, Novartis, GE Healthcare, Pfizer, GlaxoSmithKline, and Schwarz.
Durval Costa, MD, MSc, PhD, FRCR
Dr. Costa has indicated that he is part owner of HPP Medicina Molecular, SA
Svetislav Gacinovic, MD, MSc
The disclosure information for Dr. Gacinovic is to be confirmed. He will disclose of any financial
interests or relationships prior to his presentation.
Donald Grosset, BSc, MBChB, MD, FRCP
Dr. Grosset is a consultant for GE Healthcare, Schwarz, and Vectura and has received grant/research support from GlaxoSmithKline Pharmaceuticals and Vectura, and has also received honoraria from Solvay, GlaxoSmithKline, Orion and Schwarz.
Andrew Lees, MD, FRCP
Prof. Lees has indicated that he does not have any relevant financial relationships to disclose.
Wolfgang Oertel, MD
Prof. Oertel is a consultant for Boehringer Ingelheim, Eisai, GlaxoSmithKline, Novartis, Orion, Pfizer, Roche, SchwarzBioscience, Servier and Solvay. He is also one of the patent holders for pramipexole in the indication restless legs syndrome.
Werner Poewe, MD
Dr. Poewe has indicated that he does not have any relevant financial relationships to disclose.
Philippe Remy, MD, PhD
Dr. Remy is a consultant for Sanofi-Aventis.
Christoph Scherfler, MD
Dr. Schefler has indicated that he does not have any relevant financial relationships to disclose
Eduardo Tolosa, MD
Prof. Tolosa is a consultant for Boheringer Ingelheim, Teva, Sanofi, Servier, Lunbeck, and General Electric, receives grants/research support from Novartis, and has also received honoraria from Boehringer Ingelheim, Teva, Sanofi, Servier, Lundbeck, Amersham, and Novartis.